Persistent Asset Partners Ltd Makes New $640,000 Investment in Synopsys, Inc. $SNPS

Persistent Asset Partners Ltd purchased a new position in Synopsys, Inc. (NASDAQ:SNPS) in the 3rd quarter, Holdings Channel reports. The firm purchased 1,298 shares of the semiconductor company’s stock, valued at approximately $640,000.

A number of other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. raised its stake in Synopsys by 20.7% during the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock valued at $8,970,415,000 after buying an additional 3,120,401 shares during the last quarter. State Street Corp increased its position in Synopsys by 1.2% during the second quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock valued at $3,725,362,000 after acquiring an additional 85,662 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Synopsys by 1.5% in the second quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock valued at $1,810,214,000 after acquiring an additional 51,043 shares during the period. Ameriprise Financial Inc. boosted its position in Synopsys by 29.1% in the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after purchasing an additional 585,494 shares during the last quarter. Finally, Alliancebernstein L.P. grew its stake in shares of Synopsys by 10.9% during the 2nd quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock valued at $980,757,000 after purchasing an additional 187,790 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Janet Lee sold 250 shares of the company’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider owned 11,959 shares in the company, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 4,157 shares of company stock worth $1,945,036 in the last 90 days. 0.62% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

SNPS has been the subject of several recent research reports. Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and cut their target price for the company from $525.00 to $500.00 in a research report on Monday, December 8th. Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. Morgan Stanley raised their target price on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. KeyCorp lifted their target price on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Finally, JPMorgan Chase & Co. upped their price target on Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $553.57.

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $442.44 on Friday. The firm has a fifty day moving average price of $474.32 and a 200 day moving average price of $485.28. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The firm has a market cap of $84.65 billion, a price-to-earnings ratio of 55.37, a P/E/G ratio of 3.68 and a beta of 1.12. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.11. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.25 billion. During the same period in the previous year, the firm posted $3.40 earnings per share. The business’s revenue was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, sell-side analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.